Skip to content

Author

B. Farag

We have 4 of 52 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Nano route with DFT, docking studies, ADMET, and SAR of a pyran-functionalized pyrimidine scaffold as a potent Rhizoctonia solani

Numerous plant infections known as phytopathogenic fungi are responsible for a broad range of agricultural illnesses. Recent research focuses on developing, synthesizing, and evaluating pyran-linked pyrimidine hybrids as potential antifungals. In this study, the target hybrids of the pyran-functionalized pyrimidine sca...

B. Farag, G. El-Bana, H. A. Abd El-Lateef et al. · 0 citations
Open access Sep 2026

Quinazoline-tethered thiazolo[3,2-a]pyrimidines and their cyclic chalcone derivatives as HIV-1 reverse transcriptase inhibitors: green synthesis, molecular docking, and in silico studies

Nitrogen-fused heterocycles have attracted considerable research interest in pharmaceutical, medicinal, organometallic, and materials chemistry. In this work, two new series of quinazoline-linked thiazolo[3,2-a]pyrimidines and their cyclic chalcone derivatives were synthesized using choline hydroxide as an environmenta...

S. M. Gomha, Sami A. Alhussain, Yaser A. M. Sulaiman et al. · 0 citations
Open access Sep 2026

Synthesis, Cytotoxic Evaluation, Molecular Docking, and In Silico ADME Studies of Novel Quinazolinone-Based Aldazine Derivatives Using Chitosan Sulfonic Acid as a Recyclable Catalyst

A series of novel quinazolinone-based aldazine and ketazine derivatives (4a–l and 6) was synthesized through the condensation of hydrazine intermediate 2 with substituted aldehydes and isatin using chitosan sulfonic acid (CS–SO3H) as a recyclable heterogeneous catalyst. The reactions were performed under conventional r...

Tariq Z. Abolibda, Yousef R. Alsuhaymi, B. Farag et al. · 0 citations
Open access Aug 2026

Neuroprotective potential of synthesized coumarin-based glycinate and heterocyclic amide derivatives: an acetylcholinesterase inhibition study

It is suggested that Se-NPs act as effective nanocatalysts for organic transformations and as efficient carriers that enhance the biological activity of the conjugated compounds, supporting their potential application as multifunctional platforms for neuroprotective therapy in Alzheimer’s disease.

B. Farag, Wesam S. Shehab, Hanan F. Aly et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.